What risk of piroxicam photodermatitis in thimerosal-positive patients?
Stingeni
L
L
Department of Medical and Surgical Specialities, University of Perugia, Italy.
Lapomarda
V
V
Lisi
P
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D001565:Benzoates / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D010787:Photosensitivity Disorders / Q000139:chemically induced* / Q000175:diagnosis; D010894:Piroxicam / Q000009:adverse effects*; D012307:Risk Factors; D013438:Sulfhydryl Compounds; D013849:Thimerosal / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000935:Antifungal Agents; D001565:Benzoates; D013438:Sulfhydryl Compounds; D010894:Piroxicam; C026196:2-thiosalicylic acid; D013849:Thimerosal